High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells

Blood

Volumn 105, Issue 5, 2005, Pages 2000-2006

  Wettinger, Stephanie Bezzina ^b   Doggen, Carine J M ^b   Spek, C Arnold ^b   Rosendaal, Frits R ^b   Reitsma, Pieter H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CONTROLLED STUDY; GENETIC MARKER; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; INFLAMMATORY CELL; LEUKOCYTE; MACROPHAGE MIGRATION; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; UPREGULATION;

ADULT; AGED; BLOOD CELLS; CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LEUKOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; RNA, MESSENGER; SERPINS; UP-REGULATION;

EID: 14944352993     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-08-3283     Document Type: Article

References (30)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874
2. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002;252:283-294.
3. Weiss G, Willeit J, Kiechl S, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis. 1994; 106:263-271.
4. Schumacher M, Eber B, Tatzber F, Kaufmann P, Esterbauer H, Klein W. Neopterin levels in patients with coronary artery disease. Atherosclerosis. 1992;94:87-88.
5. Tatzber F, Rabl H, Koriska K, et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis. 1991;89:203-208.
6. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-518.
7. Ettinger WH, Jr., Sun WH, Binkley N. Kouba E, Ershler W. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J Gerontol A Biol Sci Med Sci. 1995;50:M137-M140.
8. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103:1194-1197.
9. Doggen CJ, Berckmans RJ, Sturk A, Manger Cats V, Rosendaal FR. C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men. J Intern Med. 2000; 248:406-414.
10. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noorda J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28:495-503.
11. Spek CA, Verbon A, Aberson H, et al. Treatment with an anti-CD 14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol. 2003; 23:132-140.
12. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955; 19:251-253.
13. Lehmann LE, Novender U, Schroeder S, et al. Plasma levels of macrophage migration inhibi-tory factor are elevated in patients with severe sepsis. Intensive Care Med. 2001;27:1412-1415.
14. Meazza C, Travaglino P, Pignatti P, et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002; 46:232-237.
15. Yamaguchi E, Nishihira J, Shimizu T, et al. Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy. 2000;30:1244-1249.
16. Donnelly SC, Haslett C, Reid PT, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 1997;3:320-323.
17. Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003;199:496-508.
18. Calandra T, Bucala R. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm. 1995;47:39-51.
19. Hudson JD, Shoaibi MA, Maestro R, Camera A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med. 1999;190:1375-1382.
20. Yu CM, Lau CP, Lai KW, Huang XR, Chen WH, Lan HY. Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol. 2001;88:774-777.
21. Takahashi M, Nishihira J, Shimpo M, et al. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res. 2001;52:438-445.
22. Hirst CE, Buzza MS, Bird CH, et al. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol. 2003;170:805-815.
23. Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schonbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1 beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med. 2000; 191:1535-1544.
24. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78:273-277.
25. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vase Biol. 2002;22:1668-1673.
26. Akatsu T, Nakamura M, Satoh M, Hiramori K. Increased mRNA expression of tumor necrosis factor-alpha and its converting enzyme in circu-lating leukocytes of patients with acute myocardial infarction. Clin Sci (Lond). 2003;105:39-44.
27. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RR, Sanders GT. lnterleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med. 1992;119:574-579.
28. Shibata M, Endo S, Inada K, et al. Elevated plasma levels of interleukm-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res. 1997; 17:145-150.
29. Paulus WJ. How are cytokines activated in heart failure? Eur J Heart Fail. 1999;1:309-312.
30. Haferlach T, Kohlmann A, Kern W, Hiddemann W, Schnittger S, Schoch C. Gene expression profiling as a tool for the diagnosis of acute leukemias. Semin Hematol. 2003;40:281-295.